TULSA-PRO combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The system is designed to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while actively protecting the urethra and rectum aiming to preserve the patient’s natural functional abilities1. TULSA-PRO is CE marked, Health Canada approved, and 510(k) cleared by the U.S. Food and Drug Administration (FDA).
1. Klotz, et al. “MP46-03-Pivotal trial of MRI-guided transurethral ultrasound ablation in men with localized prostate cancer: Three-year follow-up”. The Journal of Urology Suppl (2021)
Booth Activities
Join us during the RSNA Happy Hour!
Dec 3rd 2024| 3:00 PM – 5:00 PM
Meet the Profound Team
Participate in the Contouring Challenge
Scientific Poster Sessions
Joseph J. Busch, MD
Customized whole-gland MRI-Guided transurethral ultrasound ablation (TULSA) for treatment of localized prostate cancer: A single centre retrospective analysis of 73 patients | W2-SPIR-2
Dec 4th | 9:00 AM – 9:30 AM CST
Daniel N. Costa, MD
Real-world efficacy of MRI-Guided transurethral ultrasound ablation of the prostate: Initial report from the customized ablation registry (CARE) | W5B-SPGU-6
Dec 4th | 12:45 PM – 1:15 PM CST